NCT06311227 2026-03-19Venetoclax for the Treatment of Patients With Relapsed Hairy Cell LeukemiaNational Cancer Institute (NCI)Phase 2 Recruiting20 enrolled
NCT01841723 2026-03-18Ibrutinib in Treating Patients With Relapsed Hairy Cell LeukemiaNational Cancer Institute (NCI)Phase 2 Active not recruiting44 enrolled